Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.

NCT03438981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-04-28

No results posted yet for this study

Summary

WP2.1. PK/PD target attainment Plasma exposure ELF exposure WP2.2. Predictive dosing algorithm WP2.3. ECMO subset

Conditions

  • Pharmacokinetics
  • Critical Illness

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER
  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2018-02-28
Completion
2019-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03438981 on ClinicalTrials.gov